公开(公告)号：US20150368251A1

公开(公告)日：2015-12-24

申请号：US14765906

申请日：2014-02-04

Applicant: BRISTOL-MYERS SQUIBB COMPANY

Inventor： Tao WANG ,  Zhongxing ZHANG ,  Eric GILLIS ,  Paul Michael SCOLA

IPC: C07D487/08 ,  A61K31/53

CPC classification number: C07D487/08 ,  A61K31/53 ,  C07D498/08

Abstract: Compounds of Formula I, including pharmaceutically acceptable salts thereof, are set forth, in addition to compositions and methods of using these compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.

Abstract translation: 除了使用这些化合物的组合物和方法之外，还列举了式I化合物，包括其药学上可接受的盐。 该化合物具有抗丙型肝炎病毒（HCV）的活性，可用于治疗HCV感染者。